{"id":3557,"date":"2011-10-13T08:38:00","date_gmt":"2011-10-13T16:38:00","guid":{"rendered":"http:\/\/www.foodanddrugrecall.org\/index.php\/fda-drug-safety-podcast-for-healthcare-professionals-sprycel-dasatinib-and-risk-of-pulmonary-arterial-hypertension\/"},"modified":"2011-10-13T08:38:00","modified_gmt":"2011-10-13T16:38:00","slug":"fda-drug-safety-podcast-for-healthcare-professionals-sprycel-dasatinib-and-risk-of-pulmonary-arterial-hypertension","status":"publish","type":"post","link":"https:\/\/www.foodanddrugrecall.org\/index.php\/fda-drug-safety-podcast-for-healthcare-professionals-sprycel-dasatinib-and-risk-of-pulmonary-arterial-hypertension\/","title":{"rendered":"FDA Drug Safety Podcast for Healthcare Professionals: Sprycel (dasatinib) and risk of pulmonary arterial hypertension"},"content":{"rendered":"

On October 11, 2011, the Food and Drug Administration issued a Drug Safety Communication warning the public that the leukemia drug Sprycel, active ingredient dasatinib, may increase the risk of a rare, but serious condition in which there is abnormally high blood pressure in the arteries of the lungs, known as pulmonary arterial hypertension, or PAH.<\/p>\n","protected":false},"excerpt":{"rendered":"

On October 11, 2011, the Food and Drug Administration issued a Drug Safety Communication warning the public that the leukemia drug Sprycel, active ingredient dasatinib, may increase the risk of a rare, but serious condition in which there is abnormally high blood pressure in the arteries of the lungs, known as pulmonary arterial hypertension, or … Continue reading FDA Drug Safety Podcast for Healthcare Professionals: Sprycel (dasatinib) and risk of pulmonary arterial hypertension<\/span> →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"1","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-3557","post","type-post","status-publish","format-standard","hentry","category-drug-safety-information-podcasts"],"_links":{"self":[{"href":"https:\/\/www.foodanddrugrecall.org\/index.php\/wp-json\/wp\/v2\/posts\/3557","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.foodanddrugrecall.org\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.foodanddrugrecall.org\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.foodanddrugrecall.org\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.foodanddrugrecall.org\/index.php\/wp-json\/wp\/v2\/comments?post=3557"}],"version-history":[{"count":0,"href":"https:\/\/www.foodanddrugrecall.org\/index.php\/wp-json\/wp\/v2\/posts\/3557\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.foodanddrugrecall.org\/index.php\/wp-json\/wp\/v2\/media?parent=3557"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.foodanddrugrecall.org\/index.php\/wp-json\/wp\/v2\/categories?post=3557"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.foodanddrugrecall.org\/index.php\/wp-json\/wp\/v2\/tags?post=3557"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}